IOL CHEMICALS AND PHARMACEUTICALS LIMITED

IOL Chemicals and Pharmaceuticals Limited

IOLCP

INE485C01011

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:48 2024-04-19 am EDT			5-day change	1st Jan Change
384.6 ^INR	-1.18%		-2.65%	-16.98%

Mar. 19	IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units	MT
Feb. 19	IOL Chemicals Gets Nod to Export Diabetes Drug to China	MT

IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022

August 09, 2022 at 10:34 am EDT

IOL Chemicals and Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 5,650.1 million. Revenue was INR 5,701.7 million. Net income was INR 346.7 million. Basic earnings per share from continuing operations was INR 5.91.

Latest news about IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units	Mar. 18	MT
IOL Chemicals Gets Nod to Export Diabetes Drug to China	Feb. 19	MT
IOL Chemicals and Pharmaceuticals Limited Announces CDE, China Approved Metformin Hydrochloride	Feb. 19	CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 08, 2024	Feb. 08
IOL Chemicals and Pharmaceuticals Limited Approves Closing of M/S Iol Global Limited, Uk, Wholly Owned Subsidiary of the Company	Feb. 06	CI
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Financial Year 2023-24	Feb. 06	CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 06	CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 09, 2023	Nov. 09
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q1 2024 Earnings Call, Aug 16, 2023	23-08-16
CARE Keeps A+ Rating on IOL Chemicals' Long-term Bank Financing; Outlook Stable	23-06-30	MT
IOL Chemicals Opens New Acetic Anhydride Facility	23-06-12	MT
IOL Chemicals Granted New Patent in India	23-05-29	MT
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q4 2023 Earnings Call, May 09, 2023	23-05-09
IOL Chemicals Gets European Drug Regulator's Approval to Export Paracetamol	23-05-08	MT
IOL Chemicals and Pharmaceuticals Receives Cep for Paracetamol to Export in European Market	23-05-08	CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-04-28	CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-04-28	CI
IOL Chemicals Appoints CEO	23-04-05	MT
IOL Chemicals and Pharmaceuticals Appoints Vikas Vij as CEO	23-04-04	CI
IOL Chemicals and Pharmaceuticals Limited Announces Resignation of Sanjay Chaturvedi as CEO	23-04-03	CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q3 2023 Earnings Call, Feb 09, 2023	23-02-09
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Fiscal Year 2023, Payable Before 8 March 2023	23-02-07	CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-07	CI
IOL Chemicals & Pharmaceuticals Forms New Unit in UK	23-02-01	MT

Chart IOL Chemicals and Pharmaceuticals Limited

Duration

Period

Chart IOL Chemicals and Pharmaceuticals Limited

More charts

Company Profile

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical, and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) include Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin. Its Specialty Chemical division includes Ethyl Acetate, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and paint industry.

Sector

Pharmaceuticals

Calendar

2024-05-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for IOL Chemicals and Pharmaceuticals Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

384.6 INR

Average target price

517 INR

Spread / Average Target

+34.43%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
IOL CHEMICALS AND PHARMACEUTICALS LIMITED	-16.98%	273M
ELI LILLY AND COMPANY	+24.54%	672B
NOVO NORDISK A/S	+24.08%	550B
JOHNSON & JOHNSON	-5.78%	351B
MERCK & CO., INC.	+15.49%	317B
ABBVIE INC.	+7.37%	292B
ASTRAZENECA PLC	+3.26%	211B
NOVARTIS AG	+0.78%	203B
PFIZER, INC.	-9.81%	144B
AMGEN INC.	-6.69%	141B

Other Pharmaceuticals